ClinicalTrials.gg
Sign In

Tuberculosis clinical trials

The registry lists 1,170 studies for Tuberculosis across more than 10 countries. 175 are recruiting or about to start. 766 of them are mainly about Tuberculosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 5 narrower conditions too, such as Tuberculosis, Pulmonary: 1,547 studies, 260 open.

ClinicalTrials.gov finds 1,672 studies for Tuberculosis. How that becomes 1,168 here

This page counts the studies the registry files under Tuberculosis, and those it files under no condition that list Tuberculosisthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,672Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −376Filed under a narrower condition, counted on its own pageTuberculosis, Pulmonary 183 · Latent Tuberculosis 100 · Tuberculosis, Multidrug-Resistant 62 · Tuberculosis, Meningeal 21
  3. −31List Tuberculosis as a condition, but the registry did not file them under itMost often written as “Mycobacterium Tuberculosis” (3), “Intestinal Tuberculosis” (3), and “Extrapulmonary Tuberculosis” (3). The registry filed 1 of them under no condition at all, and the others under other conditions only, most often Tuberculosis, Extrapulmonary (5) and Crohn Disease (3).
  4. −97Match it another way35 name it in the title, 10 in a keyword, and 52 by a synonym or other text the search reads.
  5. 1,168The count on this page23 of them list Tuberculosis in their own words; the registry filed them under no condition.

Get an email when these change. Save the Tuberculosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
747
Status unknown
143
Recruiting
109
Not yet recruiting
57
Terminated
41
Active, not recruiting
38

Phase

Phase 2
197
Phase 1
179
Phase 3
116
Phase 4
70
Early Phase 1
7

Where

South Africa
210
United States
129
Uganda
90
United Kingdom
65
India
64
China
62

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (78) · University of Oxford (36) · Johns Hopkins University (26) · Global Alliance for TB Drug Development (26) · University of Cape Town (23) · Centers for Disease Control and Prevention (21) · Aeras (20) · GlaxoSmithKline (19)

What is being tested here

Drugs under test in Tuberculosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Isoniazid101955
Rifampin6833
Rifapentine61026
Moxifloxacin4621
Pyrazinamide4520
Acetylcysteine437
Linezolid3515
Ethambutol3513
Atorvastatin324
BCG Vaccine2220

Drug classes tested here Statins 3 open · Integrase inhibitors 2 open · Corticosteroids 1 open · Hormonal contraceptives 1 open · Reverse transcriptase inhibitors 18

Coming up

26phase 3 studies under way
58studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 109 Tuberculosis studies recruiting now, 64 (59%) set no upper age limit and 35 (32%) stop at 75 or younger. 48 (44%) take children under 18. 3 (3%) are for women only and 2 (2%) for men only; 30 (28%) take healthy volunteers.

Recruiting studies that take each age, of 109
AgeWomenMen
1025 (23%)25 (23%)
1888 (81%)87 (80%)
3090 (83%)89 (82%)
4091 (83%)90 (83%)
5091 (83%)90 (83%)
6587 (80%)88 (81%)
7575 (69%)76 (70%)
8570 (64%)71 (65%)

Across all 1,170 studies, recruiting or not: 41% stop at 75 or younger and 38% at 65; 34% take children; 2% are for women only and 3% for men only; 34% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Tuberculosis studies take

Of 63 phase 2 interventional studies under Tuberculosis, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 110 mo3–25 · 59 studies—13 mo3–30 · 40 studies
Phase 1/239 mo25–53 · 18 studies——
Phase 224 mo15–36 · 63 studies—24 mo15–37 · 43 studies
Phase 355 mo38–76 · 40 studies—54 mo38–67 · 33 studies
Phase 436 mo26–47 · 22 studies——
Interventional, no phase25 mo14–41 · 171 studies—25 mo15–41 · 169 studies
Observational36 mo21–76 · 134 studies—41 mo24–76 · 122 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting3

Newly registered6

Show 1 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,170. Browse all 1,170 → or search them.